KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies

Ignace Vergote, Bente Lund, Z Ujmajuridze, H. Havsteen, T Rashal, J McCartney, M Kauffman, S Shacham, Mansoor Raza Mirza

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftInternational Journal of Gynecological Cancer
Vol/bind29
Udgave nummer9, 4 suppl.
Sider (fra-til)1182
ISSN1048-891X
StatusUdgivet - 2014
BegivenhedBiennial Meeting of the International Gynecologic - Melbourne, Australien
Varighed: 8 nov. 201411 nov. 2014
Konferencens nummer: 15th

Konference

KonferenceBiennial Meeting of the International Gynecologic
Nummer15th
LandAustralien
ByMelbourne
Periode08/11/201411/11/2014

Citer dette

Vergote, Ignace ; Lund, Bente ; Ujmajuridze, Z ; Havsteen, H. ; Rashal, T ; McCartney, J ; Kauffman, M ; Shacham, S ; Mirza, Mansoor Raza. / KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies. I: International Journal of Gynecological Cancer. 2014 ; Bind 29, Nr. 9, 4 suppl. s. 1182.
@article{f41753c4dc7f41adb4799ba341ccb29a,
title = "KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies",
author = "Ignace Vergote and Bente Lund and Z Ujmajuridze and H. Havsteen and T Rashal and J McCartney and M Kauffman and S Shacham and Mirza, {Mansoor Raza}",
year = "2014",
language = "English",
volume = "29",
pages = "1182",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams & Wilkins, Ltd.",
number = "9, 4 suppl.",

}

KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies. / Vergote, Ignace; Lund, Bente; Ujmajuridze, Z; Havsteen, H.; Rashal, T; McCartney, J; Kauffman, M; Shacham, S; Mirza, Mansoor Raza.

I: International Journal of Gynecological Cancer, Bind 29, Nr. 9, 4 suppl., 2014, s. 1182.

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

TY - ABST

T1 - KCP-330-005/SIGN: A phase II, open-label study of efficacy and safety of the selective inhibitor of nuclear export (SINE) KPT-330 (SELINEXOR) in patients with advanced gynaecologic malignancies

AU - Vergote, Ignace

AU - Lund, Bente

AU - Ujmajuridze, Z

AU - Havsteen, H.

AU - Rashal, T

AU - McCartney, J

AU - Kauffman, M

AU - Shacham, S

AU - Mirza, Mansoor Raza

PY - 2014

Y1 - 2014

M3 - Conference abstract in journal

VL - 29

SP - 1182

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 9, 4 suppl.

ER -